Optometrists in Kutztown, PA Accepting Medicare

3 Optometrists found. Showing 1 - 3

Dr Marlon Burt Od Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 126 W Main St, Kutztown, PA 19530 Phone: 610-683-3888    Fax: 610-683-3083

Andrew Larson, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 93 Constitution Blvd, Kutztown, PA 19530 Phone: 610-683-3888    Fax: 610-683-3083

Marlon G Burt, OD Optometrist Medicare: Accepting Medicare Assignments Practice Location: 93 Constitution Blvd, Kutztown, PA 19530 Phone: 610-683-3888    Fax: 610-683-3083

News Archive

Researchers identify compound that inhibits viral replication

Broad-spectrum antibiotics, which are active against a whole range of bacterial pathogens, have been on the market for a long time. Comparably versatile drugs to treat viral diseases, on the other hand, have remained elusive. Using a new approach, research teams led by Dr. Albrecht von Brunn of LMU Munich and Professor Christian Drosten from the University of Bonn have identified a compound that inhibits the replication of several different viruses, including the highly aggressive SARS virus that is responsible for severe acute respiratory syndrome.

Connective tissue protein promotes immune responses that fight bacterial infections

A connective tissue protein known to support the framework of organs also encourages immune responses that fight bacterial infections, while restraining responses that can be deadly in the condition called sepsis, a new study finds.

AOSSM to present ten research awards and seven grants during annual meeting in Baltimore

In order to recognize and encourage cutting-edge research in key areas of orthopaedic sports medicine, the American Orthopaedic Society for Sports Medicine (AOSSM) will present ten research awards and seven grants during its Annual Meeting, July 12-15 in Baltimore, MD. As a leader in orthopaedic sports medicine, AOSSM annually provides more than $350,000 to research initiatives and projects around the country.

VIVUS submits a NDA to the FDA for obesity drug Qnexa

VIVUS, Inc., a biopharmaceutical company developing innovative, next-generation medical therapies to address unmet needs in obesity, diabetes and sexual health, announced today that a New Drug Application (NDA) has been submitted to the U.S. Food and Drug Administration (FDA) seeking approval of Qnexa, its investigational drug for the treatment of obesity, including weight loss and maintenance of weight loss, in patients who are obese or overweight with co-morbidities such as hypertension, type 2 diabetes, dyslipidemia or central adiposity.

Implementation roundup: HHS meets on state exchanges; Regs out soon on 'unreasonable' insurance rate increases; Plan 'B' options for the individual mandate

The first of a two-day, closed-door, HHS meeting with representatives from 44 states suggested that in many cases states will delay passing laws to create health insurance exchanges until 2012, according to one attendee. ... States have flexibility under the law to structure exchanges in different ways. HHS has urged that, if possible, they begin passing legislation in 2011 to get that process underway (Reichard, 12/16).

Read more Medical News

› Verified 5 days ago